Message Font: Serif | Sans-Serif
No. of Recommendations: 0
So I've been thinking over the weekend what Questcor's plans are for the future. They have repeatedly said that they are not looking for another drug and just want to continue to focus on Acthar and its 19 indications.

I personally think Questcor management as astute. They have made all the right decisions to take Acthar to near blockbuster status and have made a ton of money for shareholders along the way.

So they are kind of at a cross-roads here. Acthar has taken the company beyond, and now, management has tons of cash to draw upon. If you were management, what would you do?

Some ideas:

- Take Acthar international
- Partner with a major drug company
- Develop or buy another drug/company (although management has said they have no plans for this)

I'm fairly excited to see what management will do. The stock is down since the JP Morgan Healthcare conference probably because the company did not offer any hints or provide additional information on scripts other than they are greater than last quarter...which is good news, but analysts were hoping for more information.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.